Communitarian societies and public engagement in public health

Critical Public Health

Volumn 27, Issue 1, 2017, Pages 6-13

  Oluwatoyin Folayan, Morenike ^a,b   Haire, Bridget ^c  

^a New HIV Vaccine and Microbicide Advocacy Society   (Nigeria)

^b OBAFEMI AWOLOWO UNIVERSITY   (Nigeria)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

communitarian; Ebola; ethics; participation; West Africa

Indexed keywords

COMMUNITY CARE; GOVERNMENT; HEALTH CARE PLANNING; HEALTH PROGRAM; HUMAN; INTERVENTION STUDY; NOTE; PSYCHOLOGIC ASSESSMENT; PUBLIC HEALTH; RESEARCH;

EID: 84994168931     PISSN: 09581596     EISSN: 14693682     Source Type: Journal    
DOI: 10.1080/09581596.2016.1252035     Document Type: Note

References (43)

1. Adebamowo, C., Bah-Sow, O., Binka, F., Bruzzone R., Caplan A., Delfraissy J. F., … Whitehead J., (2014). Randomised controlled trials for Ebola:Practical and ethical issues. The Lancet, 384, 1423–1424.10.1016/S0140-6736(14)61734-7
2. Alexander, K. A., Sanderson, C. E., Marathe, M., Lewis, B. L., Rivers, C. M., Shaman, J., … Eubank, S., (2015). What factors might have led to the emergence of Ebola in West Africa? PLoS Neglected Tropical Diseases, 9, e0003652.10.1371/journal.pntd.0003652
3. Amazigo, U., (2008). The African Programme for Onchocerciasis Control (APOC). Annals of Tropical Medicine & Parasitology, 102, 19–22.10.1179/136485908X337436
4. Amazigo, U. V., Leak, S. G. A., Zoure, H. G. M., Njepuome, N., & Lusamba-Dikassa, P.-S., (2012). Community-driven interventions can revolutionise control of neglected tropical diseases. Trends in Parasitology, 28, 231–238.10.1016/j.pt.2012.03.002
5. Bah, C. A. M., (2015). The Ebola outbreak in West Africa:Corporate gangsters, multinationals and rogue politicians. Philadelphia, PA:Africanist Press.
6. BBC. (2014, September 19). Ebola outbreak:Guinea health team killed. Retrieved September 14, 2016, from http://www.bbc.com/news/world-africa-29256443
7. Callahan, D., (2003). Individual good and common good:A communitarian approach to bioethics. Perspectives in Biology and Medicine, 46, 496–507.
8. Caplan, A. L., Plunkett, C., & Levin, B., (2015). Selecting the right tool for the job. The American Journal of Bioethics, 15, 4–10.10.1080/15265161.2015.1010993
9. Carrión Martín, A. I., Derrough, T., Honomou, P., Kolie, N., Diallo, B., Koné, M., … Jansà, J. M., (2016). Social and cultural factors behind community resistance during an Ebola outbreak in a village of the Guinean Forest region, February 2015:A field experience. International Health, 8, 227–229.10.1093/inthealth/ihw018
10. Corrigan, P. W., Larson, J. E., & Rüsch, N., (2009). Self-stigma and the “why try” effect:Impact on life goals and evidence-based practices. World Psychiatry, 8, 75–81.10.1002/wps.2009.8.issue-2
11. Degeling, C., Johnson, J., & Mayes, C., (2015). Impure politics and pure science:Efficacious Ebola medications are only a palliation and not a cure for structural disadvantage. The American Journal of Bioethics, 15, 43–45.10.1080/15265161.2015.1009563
12. Etzioni, A., (1999). The limits of privacy. New York, NY:Basic Books.
13. Etzioni, A., (2002). Public health law:A communitarian perspective. Health Affairs, 21, 102–104.10.1377/hlthaff.21.6.102
14. Folayan, M., Brown, B., Yakubu, A., Peterson, K., & Haire, B., (2014). Compassionate use of experimental drugs in the Ebola outbreak. The Lancet, 384, 1843–1844.10.1016/S0140-6736(14)61605-6
15. Folayan, M. O., Haire, B., & Peterson, K., (2015). Ethical testing of experimental Ebola treatments. JAMA, 313, 421.10.1001/jama.2014.17256
16. Folayan, M. O., & Peterson, K., (in press). Can communities declare clinical trials unethical:A case study of the oral tenofovir pre-exposure prophylaxis controversies. Medical Anthropology Theory.
17. Folayan, M. O., Peterson, K., & Kombe, F., (2015). Ethics, emergencies and Ebola clinical trials:The role of governments and communities in offshored research. Pan African Medical Journal, 22, 10.
18. Folayan, M. O., Yakubu, A., Haire, B., & Peterson, K., (2016). Ebola vaccine development plan:Ethics, concerns and proposed measures. BMC Medical Ethics, 17, 10.10.1186/s12910-016-0094-4
19. Garson, P., (2014). Liberians in US face worsening Ebola stigma. 17th October, 2014. Retrieved September 3, 2016, from http://www.irinnews.org/feature/2014/10/17
20. Gostin, L. O., (2000). Public health law:Power, duty, restraint. Berkeley:University of California Press.
21. Grant, C., (2014). Local beliefs and behaviour change for preventing Ebola in Sierra Leone. Retrieved August 1, 2016, from http://www.ebola-anthropology.net/key_messages/ebola-local-beliefs-and-behaviour-change/
22. Heymann, D. L., (2015). Ebola:Burying the bodies. The Lancet, 385, 2455–2456.
23. International Centre for Investigative Reporting. (2016, May 8). How Nigerian officials embezzled HIV/AIDS donor funds. Retrieved September 3, 2016, from http://icirnigeria.org/how-nigerian-officials-embezzled-hivaids-donor-funds/
24. Joffe, S., (2014). Evaluating novel therapies during the Ebola epidemic. JAMA, 312, 1299–1300.10.1001/jama.2014.12867
25. Laverack, G., & Manoncourt, E., (2016). Key experiences of community engagement and social mobilization in the Ebola response. Global Health Promotion, 23, 79–82.10.1177/1757975915606674
26. Levin, B. W., & Fleischman, A. R., (2002). Public health and bioethics:The benefits of collaboration. American Journal of Public Health, 92, 165–167.10.2105/AJPH.92.2.165
27. Marsh, V., Kamuya, D., Rowa, Y., Gikonyo, C., & Molyneux, S., (2008). Beginning community engagement at a busy biomedical research programme:Experiences from the KEMRI CGMRC-Wellcome Trust Research Programme, Kilifi, Kenya. Social Science & Medicine, 67, 721–733.10.1016/j.socscimed.2008.02.007
28. Masolo, D. A., (2005). Western and African communitarianism:A comparison. In K., Wiredu (Ed.), A companion to African philosophy. Oxford:Blackwell. doi:10.1002/9780470997154.ch41
29. Medecins San Frontiers. (2014, August 29). Ebola:The failure of the international outbreak response. Retrieved September 14, 2016, from http://www.msf.org/en/article/ebola-failures-international-outbreak-response
30. Morrison, C., & Dearden, A., (2013). Beyond tokenistic participation:Using representational artefacts to enable meaningful public participation in health service design. Health Policy, 112, 179–186.10.1016/j.healthpol.2013.05.008
31. Nelson, R. M., Roth-Cline, M., Prohaska, K., Cox, E., Borio, L., & Temple, R., (2015). Right job, wrong tool:A commentary on designing clinical trials for Ebola virus disease. The American Journal of Bioethics, 15, 33–36.10.1080/15265161.2015.1010018
32. Newman, P. A., Rubincam, C., Slack, C., Essack, Z., Chakrapani, V., Chuang, D. M., … Lindegger, G., (2015). Towards a science of community stakeholder engagement in biomedical HIV prevention trials:An embedded four-country case study. PLoS ONE, 10, e0135937.10.1371/journal.pone.0135937
33. Rauprich, O., (2008). Utilitarianism or communitarianism as the foundation of public health ethics? Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 51, 137–150.10.1007/s00103-008-0442-8
34. Rid, A., & Emanuel, E. J., (2014). Ethical considerations of experimental interventions in the Ebola outbreak. The Lancet, 384, 1896–1899.10.1016/S0140-6736(14)61315-5
35. Ukpong, M., & Peterson, K., (2009). Oral tenofovir controversy II:Voices from the field:A series of reports of the oral tenofovir trials from the perspectives of active community voices engaged on the field in Cambodia, Cameroon, Nigeria, Thailand and Malawi. New HIV Vaccine and Microbicide Advocacy Society. Retrieved September 3, 2016, from http://www.nhvmas-ng.org/publication/TDF2.pdf
36. Wilcox, D., (1994). Community participation and empowerment:Putting theory into practice. RRA Notes, 21, 78–82.
37. Wilkinson, A., & Leach, M., (2014). Briefing:Ebola–Myths, realities and structural violence. African Affairs, 114, 136–148.
38. Winkel, R. E., & Leary, M. R., (2004). Reactions to acceptance and rejection:Effects of level and sequence of relational evaluation. Journal of Experimental Social Psychology, 40, 14–28.
39. World Health Organisation. (2014, December). Democratic Republic of the Congo:The country that knows how to beat Ebola. Retrieved September 14, 2016, from http://www.who.int/features/2014/drc-beats-ebola/en/
40. World Health Organisation. (2015a, January). Factors that contributed to undetected spread of the Ebola virus and impeded rapid containment. Retrieved September 14, 2016, from http://www.who.int/csr/disease/ebola/one-year-report/factors/en/
41. World Health Organisation. (2016). Ebola situation report–30 March 2016. Retrieved September 14, 2016, from http://apps.who.int/ebola/ebola-situation-reports
42. World Health Organization. (2015b, April). Liberia succeeds in fighting Ebola with local, sector response. Retrieved September 14, 2016, from http://www.who.int/features/2015/ebola-sector-approach/en/
43. Zvonareva, O., Engel, N., Ross, E., Berghmans, R., Dhai, A., & Krumeich, A., (2015). Engaging diverse social and cultural worlds:Perspectives on benefits in international clinical research from South African communities. Developing World Bioethics, 15, 8–17.10.1111/dewb.2015.15.issue-1